MedPath
HSA Approval

SKIIP NICOTINE MINI LOZENGE 2 MG (MINT)

SIN16895P

SKIIP NICOTINE MINI LOZENGE 2 MG (MINT)

SKIIP NICOTINE MINI LOZENGE 2 MG (MINT)

October 30, 2023

RUBICON RESEARCH PRIVATE LIMITED

RUBICON RESEARCH PRIVATE LIMITED

Regulatory Information

RUBICON RESEARCH PRIVATE LIMITED

RUBICON RESEARCH PRIVATE LIMITED

Therapeutic

Pharmacy Only

Formulation Information

LOZENGE

**How to use Nicotine Mini Lozenge** Begin using this product on your quit day. In order to successfully quit smoking with this treatment, you should completely stop smoking. Use 1 lozenge when urge to smoke occurs; do not use more than 1 lozenge at a time. Do not use more than 1 lozenge per hour. Do not chew or swallow the lozenge. Do not eat or drink 15 minutes before using or while the lozenge is in your mouth. When starting treatment, use Nicotine Mini Lozenge 2 mg according to the following 12-week schedule: ![Skiip Dosage Table 1](https://cdn.medpath.com/drug/dosage/20240520/ac22a73c5757d03e0881a121854560f2.png) Do not use more than **5 lozenges** in 6 hours. Do not use more than **15 lozenges** per day. If an adverse event occurs with the use of the higher dose form of Nicotine Mini Lozenge, it is recommended to use the lower dose form or consult your healthcare professional. **Duration of use** For best results, you are recommended to complete the 12-week treatment course. If you are still using the lozenge after 12 weeks, you should gradually reduce the nicotine dose and discontinue when the dose has been reduced to 1–2 pieces/day. If you are still using nicotine lozenge after 6 months, talk to your healthcare professional for advice.

ORAL

Medical Information

**What you need to know about Nicotine Mini Lozenge?** Nicotine Mini Lozenge contains nicotine. When you suck the lozenge, the nicotine is slowly released and absorbed through the lining of the mouth. The lozenge can alleviate some of the unpleasant withdrawal effects that frequently occur when giving up smoking, such as cravings and irritability. The lozenge can reduce your desire to smoke and help improve your willpower to resist smoking by providing some of the nicotine previously inhaled. Nicotine Mini Lozenge is best suited for those with low nicotine dependency. It is not recommended for those who have found other forms of nicotine replacement therapy unsatisfactory. The nicotine dependence makes it difficult to stop smoking. The craving for cigarettes can continue for some time after you have ceased smoking. You still need to use your willpower to resist the urge to smoke. Advice and support will improve your success.

**Before using Nicotine Mini Lozenge** Contains 4.66 mg sodium per lozenge. Not to be taken by non-smokers. Do not use if you are allergic to nicotine or any of the other ingredients in the lozenge.

N07BA01

nicotine

Manufacturer Information

RUBICON RESEARCH PRIVATE LIMITED

Rubicon Research Private Limited

Active Ingredients

Nicotine Polacrilex eqv to Nicotine

2.00 mg

Nicotine

Documents

Patient Information Leaflets

Skiip Nicotine Mini Lozenge 2mg (Mint) PIL.pdf

Approved: October 30, 2023

Download
© Copyright 2025. All Rights Reserved by MedPath